Saturday - November 21, 2026
A New Treatment for Head and Neck Cancer
November 20, 2026
NEW HAVEN, Connecticut, Nov. 20 -- The Yale University School of Medicine issued the following news:

* * *

A New Treatment for Head and Neck Cancer

*

On Nov. 5, the U.S. Food and Drug Administration (FDA) approved the use of a new drug to treat head and neck cancer, the first in seven years. Called amivantamab, the drug is the first to target two growth receptors for head and neck cancer simultaneously, reducing the cancer's ability to ada . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products